Loading candles…
Kobo Biotech Ltd, incorporated in 1993 and formerly known as Avon Lifesciences Ltd, is an Indian pharmaceutical company focused on the manufacturing and marketing of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company's products are used in therapeutic areas including anti-diabetics and anti-asthmatics, as well as other bulk drugs. Operating within the pharmaceutical industry, Kobo Biotech serves the Indian market. There are no recorded subsidiaries, notable projects, or listings on stock exchanges associated with the company. No details on founders or key management are available.
This page is a live market overview for KOBO BIOTECH LIMITED (KOBO) on the BSE. As a listed security, KOBO BIOTECH LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for KOBO before placing trades on tick2trade.
As of the latest feed, KOBO last traded at ₹6.28 on BSE, down ₹0.33 (4.99%) from the previous close of ₹6.61. Today's session range is ₹6.28 – ₹6.28, against a 52-week band of ₹1.99 – ₹9.99. Traded volume today stands at 5.42K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for KOBO in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether KOBO is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for KOBO BIOTECH LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in KOBO. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated KOBO option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.